Cucurbitacin E (cas 18444-66-1) as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells
-
Add time:09/05/2019 Source:sciencedirect.com
Cucurbitane-type triterpenes, cucurbitacins B and E, were reported to exhibit cytotoxic effects in several cell lines mediated by JAK/STAT3 signaling. However, neither compound inhibited phosphorylation of STAT3 in human leukemia (U937) cells at low concentrations. We therefore synthesized a biotin-linked Cucurbitacin E (cas 18444-66-1) to isolate target proteins based on affinity for the molecule. As a result, cofilin, which regulates the depolymerization of actin, was isolated and suggested to be a target. Cucurbitacins E and I inhibited the phosphorylation of cofilin in a concentration-dependent manner, and their effective concentrations having the same range as the concentrations at which they had cytotoxic effects in U937 cells. In addition, the fibrous-/globular-actin ratio was decreased after treatment with cucurbitacin E in HT1080 cells. These findings suggested that the inhibition of cofilin’s phosphorylation increased the severing activity of cofilin, and then the depolymerization of actin was enhanced after treatment with cucurbitacin E at lower concentrations.
We also recommend Trading Suppliers and Manufacturers of Cucurbitacin E (cas 18444-66-1). Pls Click Website Link as below: cas 18444-66-1 suppliers
Prev:Cucurbitacin E (cas 18444-66-1) ameliorates hepatic fibrosis in vivo and in vitro through activation of AMPK and blocking mTOR-dependent signaling pathway
Next:Short reportImmunomodulatory activity of Cucurbitacin E (cas 18444-66-1) isolated from Ecballium elaterium) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short reportImmunomodulatory activity of Cucurbitacin E (cas 18444-66-1) isolated from Ecballium elaterium09/06/2019
- Cucurbitacin E (cas 18444-66-1) ameliorates hepatic fibrosis in vivo and in vitro through activation of AMPK and blocking mTOR-dependent signaling pathway09/04/2019
- Cucurbitacin E (cas 18444-66-1) ameliorates acute graft-versus-host disease by modulating Th17 cell subsets and inhibiting STAT3 activation09/03/2019
- Simultaneous determination of cucurbitacin B, E, I and E-glucoside in plant material and body fluids by HPLC–MS09/02/2019
- Derivatives of Cucurbitacin-E-glucoside produced by Curvularia lunata NRRL 2178: Anti-inflammatory, antipyretic, antitumor activities, and effect on biochemical parameters09/01/2019
-
Health and Chemical more >


